M. de Vries

Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.

C. Granger, J. Bosch, G. Montalescot, 2022, American heart journal.

Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: I. Cardiovascular Drugs.

N. van der Velde, T. Masud, J. Daams, 2018, Journal of the American Medical Directors Association.

Fall-Risk-Increasing Drugs: A Systematic Review and Meta-analysis: III. Others.

N. van der Velde, J. Daams, L. Seppala, 2018, Journal of the American Medical Directors Association.

Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics.

N. van der Velde, J. Daams, L. Seppala, 2018, Journal of the American Medical Directors Association.

Fall-Risk-Increasing Drugs: A Systematic Review and Meta-analysis: III. Others.

N. van der Velde, J. Daams, L. Seppala, 2018, Journal of the American Medical Directors Association.